Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9507
-0.0593 (-5.87%)
At close: Apr 24, 2026, 4:00 PM EDT
0.9000
-0.0507 (-5.33%)
After-hours: Apr 24, 2026, 5:54 PM EDT

CytoMed Therapeutics Revenue

In the year 2025, CytoMed Therapeutics had annual revenue of 860.85K SGD with 71.02% growth. CytoMed Therapeutics had revenue of 410.16K in the half year ending December 31, 2025, with 83.51% growth.

Revenue (ttm)
860.85K SGD
Revenue Growth
+71.02%
P/S Ratio
16.81
Revenue / Employee
20,020 SGD
Employees
43
Market Cap
11.25M USD

Revenue Chart

* This company reports financials in SGD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025860.85K357.48K71.02%
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GDTC News

More News